• Genetically engineered cell therapies, such as CAR-T and TCR cells, demonstrate outstanding efficacy in treatment of cancer

  • A new generation of cell products offers off-the-shelf stem cells for regenerative use in therapeutic areas with high unmet medical needs 


  • Haematological malignancies

  • Inflammatory and auto-immune disorders

  • Disorders of the HSC lineage

4BIO CAPITAL is a trade name of 4BIO Ventures Management Ltd, which is authorised and regulated by the Financial Conduct Authority, register number 775193
© 2015-2021 by 4BIO Ventures Management Ltd